3 assets in Adrenal Gland Hyperfunction

Therapeutic assets addressing Adrenal Gland Hyperfunction, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Osilodrostat Adrenal Gland Hyperfunction	Johns Hopkins University	P4	BBB (72)
Metyrapone Adrenal Gland Hyperfunction	Mayo Clinic	P2	CCC (53)
Semaglutide Adrenal Gland Hyperfunction	University of Texas Southwestern Medical Center	N/A	D (30)